I am not sure if I understood the difference between my position and Ms. Bruce's position. I think we're saying there is a period of time that the CDR does work and there's a period of time afterwards that each department looks at it and their drug plans to see if it's appropriate to list in their special circumstance.
I don't think the volume is so huge that it will make a big difference, but it may, depending on the size of your program. We have a fairly large program. I think we spend almost $370 million a year on drug benefits, so compared to others, we may have more capacity.